No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

(MedPage Today) -- AMSTERDAM -- Two trials from Asia weighed in on reducing components and duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) but with questionable applicability to Western practice. Both...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news